RESP (Lung Sound Monitoring System)

2023: Obtaining permission to use the device at home

The company has Strados Labs developed RESP technology, which is designed to simplify the process of monitoring lung health. This hand-free device received a second approval for use from American the regulator industries health care (), FDA 18 months after it was approved for wireless transmission data for the purpose of early detection and monitoring of respiratory diseases. This became known on June 12, 2023.

Alum Releases Wearable Asthma Control Device
Photo Source: evercare.ru

A second FDA authorization allows the device to be used at home for remote patient monitoring and telemedicine assessment. Patients will be able to monitor at home the objective symptoms of improvement or deterioration of their condition associated with pulmonary diseases. The technology is also capable of detecting pulmonary noise associated with events such as heart failure, COPD, asthma and infectious diseases such as COVID-19.

For patients and physicians, RESP provides data in a convenient form, it is integrated with electronic medical maps and provides real-time cloud access to respiratory data, and provides predictive detection and analysis with. artificial intelligence

The biosensors of the device are attached to the user's chest and determine breathing patterns and acoustic signals such as wheezing and coughing, as well as provide wireless communication with the service provider's cloud portal. With RESP, disorders can be easily noticed for any day or period of time, allowing caregiver team coordinators to remotely monitor patients' conditions^[1].

2021: RESP Announcement - Lung Sound Monitoring Systems

In mid-January 2021, the American company Strados Labs introduced its wearable system for monitoring lung sounds in real time. Previously, the device, called RESP, has already been used in clinical studies, where it was used to study the correlation between auscultatory data and various treatments, vital signs and the patient's impressions. Physicians will now be able to leverage RESP's capabilities to monitor patients directly. In addition, RESP is supposed to help scientists assess the effects COVID-19 on the lungs.

RESP attaches to the chest and, like a stethoscope, allows you to listen to normal sounds of the lungs, as well as wheezing and crepitation. Sounds are recorded and stored in the cloud in accordance with HIPAA requirements so that doctors can access them at any time. At the same time, the system suppresses most of the insignificant noise and monitors certain trends in the sounds of the lungs.

RESP Announcement - Lung Sound Monitoring Systems

This wearable technology will allow us to more effectively monitor our patients in healthcare settings, ensuring regular auscultation of the lungs between doctor visits. The sounds of the patient's lungs are archived for comparison in the future and thereby reduce the variability of auscultation documentation, which is a serious problem in both patient care and clinical research, said Strados Labs Medical Director Dr. Mitchell Glass.

Strados co-founder and CEO Nick Delmonico added that the permission to sell is an important milestone for the company's development.

Our team worked tirelessly and overcame all obstacles, including those associated with the COVID-19 pandemic, to achieve the goal. We are excited to finally introduce RESP technology to the doctors, scientists and patients who need it so much.[2]

Notes